Jones M C, Power D A, Cunningham C, Catto G R
Department of Medicine and Therapeutics, Aberdeen Royal Infirmary, Scotland.
Transplantation. 1988 Jun;45(6):1094-9. doi: 10.1097/00007890-198806000-00019.
The influence of cyclosporine (CsA) on secondary and established alloantibody responses was evaluated in inbred Lewis rats and (AO x PVG)F1 hybrid rats. Lewis rats received weekly transfusions of DA whole blood for 8 weeks either with or without cyclosporine (15 mg/kg/day) after sensitization with DA splenocytes. Hybrid rats received only CsA (10 mg/kg/day) after similar sensitization. Administration of CsA did not affect the spontaneous decline in alloantibody titers against class I (RT1A) antigens, but it was associated with a significantly reduced response to class II (RT1B) antigens at the end of the study. CsA prevented maintenance of high alloantibody titers to RT1A antigens in Lewis rats transfused repeatedly following sensitization. IgG alloantibody subclass responses were also altered by CsA with significant reduction in titers of IgG1, 2a, and 2b against RT1A antigens in rats transfused repeatedly; CsA did not, however, suppress IgG2c alloantibody levels in these animals. Responses to public RT1A antigens disappeared in most animals irrespective of their treatment group, whereas those to private and public RT1B antigens persisted unless CsA was administered. The results suggest that, contrary to results obtained with other antigens, CsA does influence secondary alloantibody responses. CsA may thus prove of value in highly sensitized dialysis patients who require further blood transfusions.
在近交系Lewis大鼠和(AO×PVG)F1杂交大鼠中评估了环孢素(CsA)对二次和已建立的同种抗体反应的影响。Lewis大鼠在用DA脾细胞致敏后,每周输注DA全血8周,输注过程中分别给予或不给予环孢素(15mg/kg/天)。杂交大鼠在类似致敏后仅给予CsA(10mg/kg/天)。给予CsA并不影响针对I类(RT1A)抗原的同种抗体滴度的自发下降,但在研究结束时,它与针对II类(RT1B)抗原的反应显著降低有关。CsA可防止致敏后反复输血的Lewis大鼠维持对RT1A抗原的高同种抗体滴度。CsA还改变了IgG同种抗体亚类反应,在反复输血的大鼠中,针对RT1A抗原的IgG1、2a和2b滴度显著降低;然而,CsA并未抑制这些动物的IgG2c同种抗体水平。无论治疗组如何,大多数动物对公共RT1A抗原的反应消失,而对私有和公共RT1B抗原的反应持续存在,除非给予CsA。结果表明,与其他抗原的结果相反,CsA确实会影响二次同种抗体反应。因此,CsA可能对需要进一步输血的高度致敏透析患者具有价值。